-+ 0.00%
-+ 0.00%
-+ 0.00%

ABBVIE - UPADACITINIB IN CROHN'S DISEASE SHOWS CLINICAL REMISSION RATES OF 78.9%-86.6% AT WEEK 144

Reuters·10/17/2026 06:03:27

Please log in to view news